相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Short-term and Divergent Regulation of FGF-19 and FGF-21 during Oral Lipid Tolerance Test but not Oral Glucose Tolerance Test
A. Schmid et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2015)
Kinetic and equilibrium studies of bile salt-liposome interactions
Lin Yang et al.
JOURNAL OF LIPOSOME RESEARCH (2015)
Short-term Regulation of Visfatin Release in vivo by Oral Lipid Ingestion and in vitro by Fatty Acid Stimulation
T. Karrasch et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Bo Angelin et al.
CELL METABOLISM (2012)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
Emerging Role of Fibroblast Growth Factors 15/19 and 21 as Metabolic Integrators in the Liver
Claudia Cicione et al.
HEPATOLOGY (2012)
Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
Holly A. Cyphert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Bile acid signaling after an oral glucose tolerance test
Silke Matysik et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2011)
The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
Tim C. M. A. Schreuder et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Bile Acid Sequestrants for Lipid and Glucose Control
Bart Staels et al.
CURRENT DIABETES REPORTS (2010)
Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment
S. Fiorucci et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice
Johanna H. M. Stroeve et al.
LABORATORY INVESTIGATION (2010)
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
Stefano Fiorucci et al.
PROGRESS IN LIPID RESEARCH (2010)
Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?
Xinjie Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
FGFs and metabolism
Alexei Kharitonenkov
CURRENT OPINION IN PHARMACOLOGY (2009)
Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry
Max Scherer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Mini-review: Endocrine actions of fibroblast growth factor 19
Stacey Jones
MOLECULAR PHARMACEUTICS (2008)
Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity
Oded Shaham et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
T. Lundasen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)